Harvest Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Buy
11,992
+43
+0.4% +$9.25K 1.5% 12
2026
Q1
$2.6M Buy
11,949
+119
+1% +$26.4K 1.45% 11
2025
Q4
$2.7M Buy
11,830
+308
+3% +$70.2K 1.53% 11
2025
Q3
$2.67M Sell
11,522
-10
-0.1% -$2.04K 1.57% 10
2025
Q2
$2.14M Sell
11,532
-37
-0.3% -$6.88K 1.38% 13
2025
Q1
$2.42M Buy
11,569
+341
+3% +$66.3K 1.75% 11
2024
Q4
$2M Sell
11,228
-23
-0.2% -$4.23K 1.38% 17
2024
Q3
$2.22M Sell
11,251
-40
-0.4% -$7.46K 1.51% 13
2024
Q2
$1.94M Buy
11,291
+37
+0.3% +$6.13K 1.43% 16
2024
Q1
$2.05M Sell
11,254
-330
-3% -$56.9K 1.53% 11
2023
Q4
$1.8M Sell
11,584
-135
-1% -$19.7K 1.44% 16
2023
Q3
$1.75M Sell
11,719
-67
-0.6% -$9.84K 1.56% 10
2023
Q2
$1.59M Buy
11,786
+10
+0.1% +$1.47K 1.36% 15
2023
Q1
$1.88M Sell
11,776
-1,100
-9% -$168K 1.67% 8
2022
Q4
$2.08M Buy
+12,876
New +$1.97M 1.95% 7

Other funds holding ABBV

Harvest Investment Advisors's ABBV Position: Q2 2026 in Review

Harvest Investment Advisors increased its AbbVie (ABBV) stake by 0.36% in Q2 2026, buying an estimated $9.25K and bringing the position to 11,992 shares worth $3.02M. The position accounts for 1.5% of the portfolio, ranked #12.

Harvest Investment Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harvest Investment Advisors held 11,992 shares of AbbVie worth $3.02M as of Q2 2026.
  • Harvest Investment Advisors bought 43 AbbVie shares in Q2 2026, an estimated $9.25K.
  • AbbVie made up 1.5% of Harvest Investment Advisors's portfolio in Q2 2026, its #12 holding.
  • Harvest Investment Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harvest Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.